Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial
Authors:
- Hans-Christoph DienerHDHans-Christoph Diener
- Reto AgostiRAReto Agosti
- Gianni AllaisGAGianni Allais
- Paul BergmansPBPaul Bergmans
- Gennaro BussoneGBGennaro Bussone
- Brendan DaviesBDBrendan Davies
- Mustafa ErtasMEMustafa Ertas
- Michel Lanteri-MinetMLMichel Lanteri-Minet
- Uwe ReuterURUwe Reuter
- Margarita Sánchez Del RíoMRMargarita Sánchez Del Río
- Jean SchoenenJSJean Schoenen
- Susanne SchwalenSSSusanne Schwalen
- 1 December 2007
- journal article
- clinical trial
- Published by Elsevier in The Lancet Neurology
- Vol. 6 (12) , 1054-1062
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Migraine prevalence, disease burden, and the need for preventive therapyNeurology, 2007
- Long‐Term Migraine Prevention With Topiramate: Open‐Label Extension of Pivotal TrialsHeadache: The Journal of Head and Face Pain, 2006
- EFNS guideline on the drug treatment of migraine – report of an EFNS task forceEuropean Journal of Neurology, 2006
- Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trialsInternational Journal Of Clinical Practice, 2005
- French guidelines for the diagnosis and management of migraine in adults and childrenClinical Therapeutics, 2004
- Clinical Utility of an Instrument Assessing Migraine Disability: The Migraine Disability Assessment (MIDAS) QuestionnaireHeadache: The Journal of Head and Face Pain, 2001
- Response to Hays et al and McHorney and Cohen: Practical Implications of Item Response Theory and Computerized Adaptive TestingMedical Care, 2000
- Divalproex Sodium in Migraine ProphylaxisCephalalgia, 1997
- A 12-Item Short-Form Health SurveyMedical Care, 1996
- Long-Term Results of Migraine Prophylaxis with Flunarizine and Beta-BlockersCephalalgia, 1991